Albert Bourla, Pfizer CEO (Gian Ehrenzeller/Keystone via AP Images)
Updating the Covid-19 vaccine: FDA offers a qualified thumbs-up ahead of adcomm
The FDA’s adcomm of outside vaccine experts will meet tomorrow to discuss how to protect the US from a likely coming wave of Omicron cases …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
